Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 16 resultaten
Zoekresultaten
-
2024
Therapeutic targeting of tumor-associated macrophages with anti-CD163 nanobody-drug conjugates as novel cancer therapy
Maksymova, L., Van Ginderachter, J., Devoogdt, N., Van Craenenbroeck, J., De Groof, T., Vincke, C., Lauwers, Y. & Raes, G., 2024. 1 blz.Onderzoeksoutput: Poster
-
Therapeutic targeting of tumor-associated macrophages with anti-CD163 nanobody-drug conjugates as novel cancer therapy
Maksymova, L., Van Ginderachter, J., Devoogdt, N., De Groof, T., Vincke, C., Lauwers, Y., Raes, G. & Van Craenenbroeck, J., 2024. 1 blz.Onderzoeksoutput: Poster
-
-
The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages.
Lauwers, Y., Devoogdt, N., De Groof, T., Raes, G., Van Ginderachter, J., Van Craenenbroeck, J. & Vincke, C., 15 mrt. 2024, (Unpublished).Onderzoeksoutput: Poster
-
The use of a CD163-specific nanobody-based immunotracer as an imaging agent to study immunosuppressive tumor-associated macrophages.
Lauwers, Y., De Groof, T., Vincke, C., Van Craenenbroeck, J., Raes, G., Devoogdt, N. & Van Ginderachter, J., 30 mei 2024, (Submitted).Onderzoeksoutput: Poster
-
2023
Blocking the MIF cytokine family to improve cancer therapy
Mora Barthelmess, R., Vincke, C., Stijlemans, B. & Van Ginderachter, J., 19 sep. 2023.Onderzoeksoutput: Poster
-
Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages
Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 16 okt. 2023.Onderzoeksoutput: Poster
-
Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages.
Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 2023.Onderzoeksoutput: Poster
-
Development of TAM-Targeted Therapies with Novel Nanobodies Against CD163
Maksymova, L., Van Craenenbroeck, J., Lauwers, Y., Haji Assadi, A., Raes, G., De Groof, T., Vincke, C., Devoogdt, N. & Van Ginderachter, J., 2023.Onderzoeksoutput: Poster
-
Intraoperative tumor visualization through a specific fluorescently-labeled anti-uPAR targeting single-domain antibody
Vangeloven, E., Mateusiak, L., Floru, S., De Groof, T., Declerck, N., Wouters, J., Janssen, S., Debie, P., Zeven, K., Vincke, C., Puttemans, J., Stroet, M., Ballet, S., Breckpot, K., Devoogdt, N. & Hernot, S., 2023, (Unpublished).Onderzoeksoutput: Poster
-
The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages
Lauwers, Y., De Groof, T., Van Craenenbroeck, J., Van Ginderachter, J., Vincke, C., Devoogdt, N. & Raes, G., 22 nov. 2023, (Unpublished).Onderzoeksoutput: Poster
-
The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages
Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 19 okt. 2023.Onderzoeksoutput: Poster
-
The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages
Lauwers, Y., Devoogdt, N., De Groof, T., Vincke, C., Raes, G., Van Ginderachter, J. & Van Craenenbroeck, J., 5 okt. 2023, (In preparation).Onderzoeksoutput: Poster
-
2022
Lipocalin-2 (Lcn-2) as a potential target in triple negative breast carcinoma
Zivalj, M., Van Ginderachter, J., Stijlemans, B. & Vincke, C., 18 okt. 2022.Onderzoeksoutput: Poster
-
Lipocalin-2 (Lcn-2) as a potential target in triple negative breast carcinoma
Zivalj, M., Van Ginderachter, J., Stijlemans, B. & Vincke, C., 19 sep. 2022.Onderzoeksoutput: Poster
-
2017
Innovative bioconjugation methods for an improved detection of ovarian cancer at early stage using multiple biomarkers
Tran, H., Smiejkowska, N. W., Vincke, C., Devoogdt, N., Muyldermans, S., Adriaensens, P. & Guedens, W., 27 sep. 2017.Onderzoeksoutput: Poster